According to a new study by researchers from the Intermountain Medical Center in Salt Lake City, heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option. Researchers found that pitavastatin, a newer cholesterol-lowering drug, may reduce the risk of heart attack, stroke and even death in up to 68 percent of patients with high cholesterol who can't tolerate other cholesterol-lowering medications due to side effects. ...
View the Original article
The rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure was reduced by a high doses of a popular cholesterol-lowering drug. This is according to a research presented at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests. Previous studies have demonstrated ...
